glp 1 conference 2025 Obesity Medicine - Preview on GLP-1 Agonists Emerging frontiers in obesity clinical
Description
Common side effects of dulaglutide include nausea, diarrhea, and abdominal distension, and these are usually mild to moderate in severity and tend to diminish over time
Whats different in 2024 is that we are seeing the birth of a major new market for effective prescription medications which promise unprecedented impact not just on obesity, but on the health issues associated with obesity
Physicians can legally prescribe GLP-1 receptor agonists for weight management in eligible patients, though prescribing patterns vary
Rischi, tapering e strategie di mantenimento
Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner
